Ask Warren

ChoA Pharmaceutical

034940 · KOSDAQ · ₩034940 · 조아제약

₩1,771▼ ₩79 (4.27%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −68.77%
Market cap
₩11B
Enterprise value
₩33B
P/E
—
P/B
0.3×
Dividend yield
0.0%
ROE
−7.9%
Net margin
−4.6%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−69.8% from the high

₩1,751Today: ₩1,751 – ₩1,870₩5,865

Returns

  • 1W−10.9%
  • 1M−33.9%
  • 3M−41.7%
  • 6M−62.2%
  • YTD−64.9%
  • 1Y−68.8%
Volume today
39,815
0.7× the 20-day average
Traded today
₩71M
Listed shares
6,195,965
EPS (12 months)
−₩454
Earnings yield −25.6%
SellBuy
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Signals

37Quiet
  • BuzzQuietBuzz 37 of 100 (50 is a normal day for this stock).
  • MomentumWeak-33.7% over the last month; the price is below its 20-day average.
  • News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

ChoA Pharmaceutical stock overview

ChoA Pharmaceutical (조아제약, KRX: 034940) is listed on KOSDAQ, in the Biotech & Pharma sector. The company was established in 1988 through the acquisition of Samgang Pharmaceutical and mainly manufactures and sells pharmaceuticals and quasi-drugs. Its shares closed at ₩1,771 on Oct 28, 2026, down 4.27% on the day, giving it a market value of ₩11B.

Key facts

Market cap
₩11B
Sector
Biotech & Pharma
Latest price change
−4.27%
As of
Oct 28, 2026
Main business
The company was established in 1988 through the acquisition of Samgang Pharmaceutical and mainly manufactures and sells pharmaceuticals and quasi-drugs.

Quick answers about ChoA Pharmaceutical

What does ChoA Pharmaceutical do?
The company was established in 1988 through the acquisition of Samgang Pharmaceutical and mainly manufactures and sells pharmaceuticals and quasi-drugs. It supplies roughly 200 medicines and health functional foods, sold mainly through pharmacies by a sales force across 15 offices nationwide, and it owns Medifarm, a nationwide pharmacy franchise chain. Its products are also exported to 23 countries, including Vietnam, Myanmar, Cambodia, China and the United States.
What is the market cap of ChoA Pharmaceutical?
The market capitalisation of ChoA Pharmaceutical was ₩11B at the close on Oct 28, 2026.
When is the next earnings report from ChoA Pharmaceutical?
Korean companies rarely announce results dates in advance. Based on when ChoA Pharmaceutical filed the same report in past years, its next 3q results is expected around Nov 14, 2026.

Company profile

The company was established in 1988 through the acquisition of Samgang Pharmaceutical and mainly manufactures and sells pharmaceuticals and quasi-drugs. It supplies roughly 200 medicines and health functional foods, sold mainly through pharmacies by a sales force across 15 offices nationwide, and it owns Medifarm, a nationwide pharmacy franchise chain. Its products are also exported to 23 countries, including Vietnam, Myanmar, Cambodia, China and the United States.

Written by AI from the company's latest annual report.

Korean name
조아제약
Sector
Biotech & Pharma
Themes
Pharmaceuticals
CEO
조성환, 조성배(각자대표)
Founded
Mar 1996
Listed
Aug 1999
Listed shares
6,195,965
Fiscal year ends
Month 12
Website
www.choa.co.kr

Similar companies

Recent news

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: ChoA Pharmaceutical / 조아제약 / 034940 / KRX:034940

Source: KRX statistical information